Which compound categories are most incompatible with Methenolone Enanthate in a stack?

High-dose aromatizing androgens and highly suppressive 19-nor compounds are the most documented incompatible categories. Supraphysiological testosterone or nandrolone doses introduce estrogenic and progestogenic activity that directly negates Methenolone's hallmark advantage of a dry, low-estrogenic tissue environment. Keeping any testosterone base below 200mg/week preserves Methenolone Enanthate's intended pharmacological role in the stack.

Does trenbolone stack favorably with Primabol 100mg/ml or does it create physiological conflicts?

Trenbolone creates a clear physiological conflict when combined with Methenolone Enanthate. Trenbolone's high androgenic potency and its well-documented suppression of LH and FSH to undetectable levels — documented in published case reports within four weeks — contradict the rationale for using a mild, low-suppression compound. The combination also amplifies hematocrit and blood-pressure risk beyond what either compound generates independently.

Can oral 17-alpha-alkylated steroids be safely added to a Methenolone Enanthate protocol?

Most 17-alpha-alkylated orals are inadvisable additions. They compound HPTA suppression already initiated by Methenolone Enanthate and impose hepatocellular stress measurable as ALT and AST elevation. Bloodwork at week four and week eight is mandatory; ASAT or ALAT values exceeding three times the upper reference limit indicate cycle-limiting liver stress. Oxandrolone is the only oral sometimes considered low-risk enough for co-administration, and even then at conservative doses.

Why does the 100mg/ml concentration of Primabol make it easier to identify and avoid dosing errors in a stack?

At 100mg/ml, each 0.5ml graduation in a 1ml syringe delivers a 50mg dose increment — the smallest practical adjustment unit when calibrating a stack. This low concentration is the easiest format for isolating and cross-checking each compound's contribution to a multi-drug protocol, particularly when reducing one compound while monitoring bloodwork response. Higher-concentration formulations compress those increments and reduce per-injection precision.

How should single-dose ampoules be stored and handled to maintain sterility during a multi-week Primabol cycle?

Each 1ml ampoule is a sealed, single-use unit; once snapped open it must be used immediately and discarded — it cannot be re-capped or re-used. Store unopened ampoules below 25°C in a dark location away from temperature fluctuations. Before opening, inspect for visible particulate matter or discoloration. The single-dose format eliminates the repeated-puncture contamination risk that accompanies multi-dose vials across a multi-week cycle. (2) angle_used

Best Selling

Omega Meds

Primabol 100mg/ml 10x1ml Ampullen by Omega Meds

Name: Primabol 100mg/ml 10x1ml Ampoules by Omega Meds
Brand: Omega Meds
SKU: INJ-METE-OME-100-018
Price: 54.00 EUR
Availability: InStock

Primabol by Omega Meds delivers Methenolone Enanthate at 100mg/ml across ten individually sealed single-dose ampoules — a format specifically suited to athletes who need precise per-injection dosing and want to evaluate unfavorable compound combinations before building a full stack. Understanding which co-administrations conflict with Methenolone's mild androgenic profile is as important as knowing what to add, since incompatible drugs can negate the compound's central advantage of low suppression and minimal estrogenic load. Each ampoule lot is released with HPLC content-assay certification and a LAL endotoxin clearance record; sterile-fill operations conform to current GMP guidelines.

€54.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Mild androgenic load allows identification of unfavorable combinations by isolating suppression variables in bloodwork
Zero aromatization confirms that any estrogenic readings in a stack originate from co-administered compounds, not Primabol itself
100mg/ml concentration enables precise per-injection adjustments when troubleshooting a stack's cumulative androgenic dose
Ten individually sealed ampoules provide per-injection sterility without cross-contamination between sessions
Nitrogen-blanketed sealing protects Methenolone Enanthate potency throughout the product shelf life
HPLC and LAL endotoxin batch certification supports objective quality verification independent of label claims
Predictable pharmacokinetic behavior over a bi-weekly injection schedule simplifies stack protocol planning

Phase	dosage	Note
Stack Assessment Phase (Weeks 1–4)	100mg/week (1ml per week, split across two 0.5ml injections)	Run Primabol as the sole anabolic to establish baseline bloodwork before any co-administration is added. Identify individual suppression depth (LH, FSH) and lipid response before introducing additional compounds.
Controlled Stack Introduction (Weeks 5–10)	200mg/week Primabol + single low-risk co-compound	Add only one additional compound at a time. Avoid high-dose aromatizing androgens and 19-nor compounds; limit testosterone base to 150–200mg/week maximum. Bloodwork at week 8 confirms no adverse interaction.
Maintenance / Pre-Competition (Weeks 11–16)	200–300mg/week Primabol	If a problematic co-administration was identified in the previous phase, remove it here and continue Primabol solo or with a confirmed low-conflict ancillary. Monitor ALT/AST if any oral was included.

Key takeaways

Avoid stacking high-dose testosterone with Primabol — estrogenic load cancels lean-tissue benefits.
Identify hepatotoxic orals as incompatible additions before finalizing any Methenolone stack.
Monitor LH, FSH, and hematocrit to catch suppression conflicts early in a combined protocol.
Use 100mg/ml single-dose ampoules to isolate and adjust each compound's dose independently.
Discard each opened ampoule immediately — single-use format mandates no resealing.

What Makes a Combination Unfavorable with Methenolone Enanthate?

Methenolone Enanthate is an injectable anabolic steroid defined primarily by what it does not do — it does not aromatize, does not exhibit progestogenic activity, and imposes a relatively shallow suppression curve on the hypothalamic-pituitary axis — and it is precisely these absences that make certain co-administrations actively counterproductive. Stacking the wrong compound with Primabol 100mg/ml does not just dilute results; in several documented patterns it directly undermines the physiological properties that users select Methenolone Enanthate to exploit.

Compounds That Conflict with Methenolone's Core Profile

High-dose aromatizing androgens represent the clearest unfavorable pairing. When supraphysiological testosterone or boldenone doses are added alongside Methenolone Enanthate, the resulting estrogenic environment introduces subcutaneous fluid retention and progesterone-receptor sensitization that cancels the dry, high-definition tissue quality Methenolone Enanthate produces. Community-reported bloodwork aggregated across harm-reduction forums consistently shows estradiol exceeding 60 pg/mL when unestered testosterone exceeds 500mg/week in a Methenolone Enanthate stack — a threshold associated with gynecomastia risk and blunted fat-partitioning response. A moderate testosterone base of 150–200mg/week as a hormonal anchor is the established alternative; anything above that progressively erodes the lean-tissue advantage Methenolone delivers.

Severe androgenic compounds — in particular trenbolone acetate or trenbolone enanthate — present a different conflict. Trenbolone's own potent AR affinity and its documented neurological and cardiovascular load sit in direct tension with the rationale for including a mild compound like Methenolone Enanthate at all. Compared to a Methenolone-only approach, adding trenbolone significantly raises hematocrit, suppresses natural testosterone production more aggressively (LH and FSH can reach undetectable levels within four weeks per multiple published case reports), and introduces androgenic side-effect density that Methenolone was specifically chosen to avoid.

Hepatotoxic Orals and Stacking Risk

Oral 17-alpha-alkylated compounds — oxandrolone excepted — create a pharmacological conflict when combined with any injectable anabolic protocol that already suppresses endogenous testosterone. Methenolone Enanthate suppresses the HPTA modestly; adding a hepatotoxic oral such as oxymetholone or stanozolol compounds suppression while imposing ALT/AST elevation that bloodwork monitoring will flag as a cycle-limiting event. ASAT and ALAT enzyme activity measured at weeks four and eight provides the earliest indicator of hepatocellular stress; values exceeding three times the upper reference limit warrant cycle interruption regardless of subjective wellbeing.

Storage and Ampoule Format as a Safety Safeguard

Omega Meds packages Primabol in 10x1ml single-dose glass ampoules, which physically prevents the cross-contamination risk inherent in multi-puncture vial formats. Each ampoule is nitrogen-blanketed at sealing to protect Methenolone Enanthate's stability across the stated shelf life. Store below 25°C away from direct light; inspect the solution for particulate matter before every draw.

Usage

Before drawing, confirm the ampoule label shows Methenolone Enanthate 100mg/ml and check the lot-specific Certificate of Analysis for HPLC potency and LAL endotoxin clearance.
Cross-reference every planned co-compound against the unfavorable combination list — high-dose aromatizing androgens, trenbolone variants, and hepatotoxic 17-alpha-alkylated orals should be removed or substituted before the first injection.
Snap the ampoule open using a sterile gauze pad, draw the full 1ml (or intended partial dose) immediately with a 21g needle, then switch to a fresh 23–25g needle for the injection site.
Administer via deep intramuscular injection into the glute or lateral deltoid; rotate sites across injections to prevent local tissue irritation from the oil depot.
Discard the ampoule and all used equipment immediately after each injection — no partial ampoule should be saved for a later session.
Schedule bloodwork at weeks 4 and 8 to assess LH, FSH, hematocrit, ALT, AST, and estradiol; use these results as the objective gate before adding or retaining any co-administered compound.

Warnings

Contraindications: Primabol is contraindicated in individuals with androgen-sensitive prostate or breast carcinoma, elevated hematocrit above 54%, active hepatic impairment, or known hypersensitivity to any sesame oil excipient component. Women of childbearing potential should not use Methenolone Enanthate due to virilization risk.

Side Effects: Androgenic effects — scalp hair thinning in predisposed individuals, mild acne — are reported at doses above 300mg/week. HDL cholesterol depression is documented with Methenolone Enanthate; total cholesterol panel should be assessed at baseline and at each monitoring interval. HPTA suppression, while milder than with 19-nor compounds, is dose-dependent and cumulative over cycle length.

Monitoring: Minimum monitoring protocol: LH, FSH, hematocrit, ALT, AST, fasting lipid panel at baseline and weeks 4 and 8. If any 17-alpha-alkylated oral is co-administered against recommendations, increase monitoring to every three weeks. Hematocrit exceeding 52% warrants dose reduction or cessation.

PCT: Because HPTA suppression is compound- and dose-dependent, PCT timing and intensity must be calibrated to the total suppression burden of the stack, not to Primabol alone. A SERM-based PCT initiated after appropriate washout of all co-administered long-ester compounds is standard practice; the specific protocol should be confirmed against week-8 LH and FSH values.

Frequently asked questions

Which compound categories are most incompatible with Methenolone Enanthate in a stack?: High-dose aromatizing androgens and highly suppressive 19-nor compounds are the most documented incompatible categories. Supraphysiological testosterone or nandrolone doses introduce estrogenic and progestogenic activity that directly negates Methenolone's hallmark advantage of a dry, low-estrogenic tissue environment. Keeping any testosterone base below 200mg/week preserves Methenolone Enanthate's intended pharmacological role in the stack.
Does trenbolone stack favorably with Primabol 100mg/ml or does it create physiological conflicts?: Trenbolone creates a clear physiological conflict when combined with Methenolone Enanthate. Trenbolone's high androgenic potency and its well-documented suppression of LH and FSH to undetectable levels — documented in published case reports within four weeks — contradict the rationale for using a mild, low-suppression compound. The combination also amplifies hematocrit and blood-pressure risk beyond what either compound generates independently.
Can oral 17-alpha-alkylated steroids be safely added to a Methenolone Enanthate protocol?: Most 17-alpha-alkylated orals are inadvisable additions. They compound HPTA suppression already initiated by Methenolone Enanthate and impose hepatocellular stress measurable as ALT and AST elevation. Bloodwork at week four and week eight is mandatory; ASAT or ALAT values exceeding three times the upper reference limit indicate cycle-limiting liver stress. Oxandrolone is the only oral sometimes considered low-risk enough for co-administration, and even then at conservative doses.
Why does the 100mg/ml concentration of Primabol make it easier to identify and avoid dosing errors in a stack?: At 100mg/ml, each 0.5ml graduation in a 1ml syringe delivers a 50mg dose increment — the smallest practical adjustment unit when calibrating a stack. This low concentration is the easiest format for isolating and cross-checking each compound's contribution to a multi-drug protocol, particularly when reducing one compound while monitoring bloodwork response. Higher-concentration formulations compress those increments and reduce per-injection precision.
How should single-dose ampoules be stored and handled to maintain sterility during a multi-week Primabol cycle?: Each 1ml ampoule is a sealed, single-use unit; once snapped open it must be used immediately and discarded — it cannot be re-capped or re-used. Store unopened ampoules below 25°C in a dark location away from temperature fluctuations. Before opening, inspect for visible particulate matter or discoloration. The single-dose format eliminates the repeated-puncture contamination risk that accompanies multi-dose vials across a multi-week cycle. (2) angle_used

Manufacturer

Omega Meds has built its injectable product line around a deliberately curated portfolio — rather than covering every pharmacological class, the brand concentrates on established compounds where dosing precision and batch-level documentation carry measurable clinical weight. Primabol sits within the brand's core anabolic injectable category alongside a focused selection of other oil-based formulations, each sharing the same quality-release framework: HPLC potency confirmation and LAL endotoxin testing completed at lot level before distribution release. This portfolio architecture means that quality-control resources are concentrated across fewer product lines, which Omega Meds positions as a structural advantage over brands that spread manufacturing oversight across a broader SKU catalogue. Each product in the injectable range is assigned an individual Certificate of Analysis traceable to the production lot, allowing end users and distributors to verify compound identity and concentration independently rather than relying solely on label claims.

Product details

Brand	Omega Meds
Active ingredient	methenolone enanthate
Also known as	Primobolan Depot, Primo, Methenolon Enanthat, Primabol, Omega Meds Primobolan Depot
Strength	100 mg
Form	Ampullen
Pack size	10 pieces
Item number	INJ-METE-OME-100-018

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Primobol 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Primobol 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Primobol by Balkan Pharmaceuticals delivers Methenolone Enanthate at 100 mg/ml across ten glass-fusion sealed, single-dose ampoules — a format rooted in the original Schering AG clinical presentation that has defined this compound since its 1960s introduction for muscle-wasting indications. The 100 mg/ml concentration reflects the benchmark established during Methenolone's first decade of human clinical use, situating Primobol as a direct continuation of a molecule with more than sixty years of documented pharmacological history. Each ampoule is manufactured under GMP Annex 1 aseptic conditions at Balkan Pharmaceuticals' Chișinău facility; HPLC potency analysis and LAL endotoxin screening are completed at batch level before release.

€55.00

Rimobolan 100mg/ml 1x1ml Ampoules by Schering

GMP Standard

Rimobolan 100mg/ml 1x1ml Ampullen by Schering

Rimobolan by Bayer is a pharmaceutical-grade injectable anabolic agent delivering Methenolone Enanthate at 100 mg/ml in a single-use 1 ml glass ampoule, produced under EU Good Manufacturing Practice regulations governed by the European Medicines Agency (EMA) framework. Each batch undergoes rigorous release testing — including HPLC-based potency verification and LAL (Limulus Amebocyte Lysate) endotoxin screening — before leaving Bayer's licensed production site. Quality assurance is built into every stage: from raw-material qualification through in-process controls to final certificate of analysis.

€6.00

High Concentration

Etho-Primobolan 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Etho-Primobolan by Beligas Pharmaceuticals is a Methenolone Enanthate injectable at 100mg/ml in a 10ml multi-dose vial, engineered to integrate seamlessly into evidence-informed modern cycling strategies — whether as a base compound, a dry-tissue phase anchor, or a bridging agent between heavier blasts. Its long-acting ester supports once- or twice-weekly injection schedules that align with the structured periodisation models favoured by contemporary competitive and recreational athletes. Quality is verified across the full production chain: each batch undergoes HPLC potency assay and LAL endotoxin testing under Beligas's GMP-certified manufacturing framework.

€68.00

Long-Acting Formula

Primabolin-100 100mg/ml 10ml Vial by BM Pharmaceuticals

Primabolin-100 is an oil-based injectable anabolic agent delivering Methenolone Enanthate at 100mg/ml — a concentration engineered for predictable, sustained plasma release governed by the enanthate ester's extended pharmacokinetic profile. With an active half-life of approximately 10–14 days, blood concentrations remain stable between injections, eliminating the rapid oscillations characteristic of short-ester Methenolone preparations. Quality assurance is embedded at the batch level: every 10ml vial passes HPLC potency verification and LAL endotoxin testing within a GMP-certified production environment operated by BM Pharmaceuticals.

€63.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00